Provenance du réseau au premier degré de Cheryl L. White
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD.
13
| Subsidiary | Biotechnology | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Cheryl L. White via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
BioTransplant, Inc.
 BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Extropy Pharmaceuticals, Inc. | Chief Executive Officer | ||
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Bock Pharmacal Co.
 Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Bock Pharmacal Co. is a wholesale pharmaceutical packaging and distribution company. The company is based in St. Louis, MO. Bock Pharmacal was acquired by Sanofi on July 17, 1996. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Beecken Petty O'Keefe & Co. LP
 Beecken Petty O'Keefe & Co. LP Investment ManagersFinance Beecken Petty O'Keefe & Co LP (BPOC) is a private equity firm founded in 1996 by Dave Beecken, Bill Petty, and Ken O’Keefe. The firm is headquartered Chicago, Illinois. | Investment Managers | Private Equity Investor | |
| University of Guelph | College/University | Doctorate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Graz | College/University | Doctorate Degree | |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
| XENO TRANSPLANTS CORPORATION | Biotechnology | Chairman | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Sandoz Pharmaceuticals Corp. | General Counsel | ||
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Chief Executive Officer | |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Private Equity Investor | |
Baxter Ventures
 Baxter Ventures Investment ManagersFinance Baxter Ventures (Baxter Ventures) is a venture capital firm subsidiary of Baxter International, Inc. founded in 2011. The firm is headquartered in Deerfield, Illinois. | Investment Managers | Corporate Officer/Principal | |
| Feinberg School of Medicine | College/University | Corporate Officer/Principal | |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Consultant / Advisor | |
TRACT Therapeutics, Inc.
 TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services TRACT Therapeutics, Inc. develops revolutionary therapeutic cells. The company was founded by Gretchen S. Johnson and Joseph R. Leventhal and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member | |
Cerevel Therapeutics LLC
 Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Ontario Veterinary College | College/University | Doctorate Degree | |
| TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Biotechnology | Director/Board Member | |
| AVITA MEDICAL, INC. | Medical Specialties | Chief Executive Officer | |
7 Hills Pharma LLC
 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | President | |
| Illinois Biotechnology Innovation Organization | Director/Board Member | ||
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 42 |
| Canada | 4 |
| Suisse | 2 |
| Autriche | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 32 |
| Finance | 7 |
| Commercial Services | 5 |
| Consumer Services | 5 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 54 |
| Corporate Officer/Principal | 50 |
| President | 14 |
| Chief Executive Officer | 14 |
| Independent Dir/Board Member | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Norbert Riedel | 29 |
| Michael Perry | 28 |
| Thomas Heinrich Glanzmann | 24 |
| Brian Dorsey | 22 |
| Joy Amundson | 15 |
| Néstor A. Molfino | 10 |
| Richard M. Murawski | 10 |
| John Shannon | 10 |
| Qin Xia | 8 |
| Siegfried S. Rogy | 6 |
| John D. Bacich | 5 |
| Thomas J Schulze | 4 |
| Simon Coles | 3 |
- Bourse
- Insiders
- Cheryl L. White
- Connexions Sociétés
